Observational studyMedicine2026
Clinical curative effect of B-ultrasound-guided minimally invasive percutaneous nephrolithotomy and its influences on stone clearance rate in patients with complex kidney stones.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study compares short-term perioperative and early postoperative outcomes of B-ultrasound-guided minimally invasive percutaneous nephrolithotomy (MPCNL) and retroperitoneal laparoscopic pyelolithotomy (RLP) in patients with complex kidney stones. This single-center retrospective observational cohort included 120 eligible patients treated between December 2020 and December 2023. Patients were classified according to the treatment actually received (RLP, n = 60; B-ultrasound-guided MPCNL, n = 60); no random allocation was performed. Outcomes included perioperative indicators, 24-hour visual analog scale pain score, 48-hour inflammatory and renal biomarkers, early ultrasound-defined stone clearance at postoperative day 1, and in-hospital complications. Operation time, intraoperative blood loss, and length of hospital stay were lower in the MPCNL group than in the RLP group (nominal P < .05). Early ultrasound-defined stone clearance was 91.67% (55/60) versus 78.33% (47/60), corresponding to a risk difference of 13.3 percentage points (95% confidence interval [CI] = 0.2-25.6), a risk ratio of 1.17 (95% CI = 1.00-1.36), and a Pearson chi-square P = .041. This comparison did not meet a conservative Bonferroni-adjusted threshold of 0.0042 for 12 reported endpoints. At 24 hours, visual analog scale scores were lower in the MPCNL group, and at 48 hours, inflammatory and renal biomarkers were lower (nominal P < .05). Complications occurred in 2/60 (3.33%) versus 8/60 (13.33%); because of sparse events, Fisher exact test was used (P = .095; risk ratio = 0.25, 95% CI = 0.06-1.13). B-ultrasound-guided MPCNL was associated with more favorable short-term perioperative and biomarker outcomes and a nominally higher early ultrasound-defined clearance rate than RLP. However, the retrospective nonrandomized design, incomplete baseline adjustment, short follow-up, outcome-measurement limitations, and multiple comparisons preclude causal or long-term effectiveness claims. These findings should be considered hypothesis-generating and require confirmation in adequately powered prospective comparative studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.